Steffi Pigorsch

Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial

Jayant S. Vaidya, Frederik Wenz, Max Bulsara et al. · The Lancet · 2013 · 832 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial

Jayant S. Vaidya, David Joseph, Jeffrey Tobias et al. · The Lancet · 2010 · 763 citations · Full text

Medicine, Oncology, Radiation Oncology +13

Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial

Jayant S. Vaidya, Max Bulsara, Michael Baum et al. · BMJ · 2020 · 289 citations · Full text

Medicine, Oncology, Surgery +17

A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling

Stefan Leger, Alex Zwanenburg, K. Pilz et al. · Scientific Reports · 2017 · 229 citations · Full text

Public Health, Biostatistics, Oncology +17

CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG)

Panagiotis Balermpas, Franz Rödel, Claus Rödel et al. · International Journal of Cancer · 2015 · 204 citations · Full text

Medicine, Oncology, Radiation Oncology +17